These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5149134)

  • 1. [Release insoluble drugs from the hydrophobic tablet matrix. 1].
    Schekerdjiski R; Trandafilov A; Michailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):632-4. PubMed ID: 5149134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Release insoluble drugs from the hydrophobic tablet matrix. 2. Influence of non-ionogenic surface-active substances].
    Schekerdjiski R; Minkov E; Mihailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):635-6. PubMed ID: 5149135
    [No Abstract]   [Full Text] [Related]  

  • 3. [Release of an easily soluble drug from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafilov T
    Pharmazie; 1972 Sep; 27(9):586-8. PubMed ID: 5086355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of auxillary substances on the release of hard-to-solve drugs from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafiloff A; Trandafiloff T
    Pharmazie; 1972 Mar; 27(3):167-8. PubMed ID: 4340367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Wood flour as an auxiliary substance in tablet forming. II. Effects of wood flour on some properties of tablets].
    Kolarski K; Krówczyński L
    Acta Pol Pharm; 1970; 27(5):477-86. PubMed ID: 5501744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obtaining of prolonged action of drugs based on insoluble matrix].
    Chodkowska-Granicka B; Michalski K; Surowiecki J; Pawlak E; Trojanowska Z
    Acta Pol Pharm; 1970; 27(3):285-90. PubMed ID: 5456904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 8. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
    Pajander J; van Veen B; Korhonen O; Lappalainen R; Ketolainen J
    Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Release of a solid, easily soluble compound from the hydrophobic tablet matrix influenced by surface-active agents].
    Schekerdschijski R; Minkov E; Guschev A; Trandafilov T
    Pharmazie; 1973 Jul; 28(7):450-2. PubMed ID: 4767492
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycerin ester of higher fatty acids as pharmaceutic aids. 6. Release of an imbedded drug from tablets containing higher fatty acids and their esters].
    Chalabala M; Starha L
    Pharmazie; 1970 Sep; 25(9):535-8. PubMed ID: 5486680
    [No Abstract]   [Full Text] [Related]  

  • 12. Disintegration and dissolution studies on amylobarbitone tablets.
    Surén G
    Acta Pharm Suec; 1970 Nov; 7(5):483-90. PubMed ID: 5488739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factors influencing the binding power of excipients for direct compression].
    Delattre L; Jaminet F
    Pharm Acta Helv; 1974; 49(3-4):108-16. PubMed ID: 4438386
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the evaluation of breaking substances in tablets].
    Modrzejewski F; Wochna L
    Pharmazie; 1966 Jun; 21(6):355-8. PubMed ID: 6000985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of burst substances in tablets].
    Hüttenrauch R; Jacob J
    Pharmazie; 1971 May; 26(5):293-8. PubMed ID: 5563062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of composition of pharmaceutic aids on the disintegration of tablets].
    Borzunov EE; Shevchenko SM
    Farmatsiia; 1969; 18(1):20-3. PubMed ID: 5770765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Choice of formulation based on the dissolution time of the active substance].
    Ceschel GC; Fabris L
    Boll Chim Farm; 1975 Jul; 114(7):408-15. PubMed ID: 1164449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Conditions of manufacture of 10% salicylic acid ointment in Vaseline which is effective for 6 months].
    Gruntová Z; Civánová L
    Cesk Farm; 1979 Dec; 28(9-10):387-90. PubMed ID: 550932
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of amphoteric tensides on the pharmaceutic availability of model drugs according to formulation].
    Bialik W; Kuferska E; Jaworski E
    Acta Pol Pharm; 1992; 49(1-2):21-3. PubMed ID: 8769076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.